related documents
- 106 What is the impact of 4D CT on the planning of esophageal cancer? Conference Paper
- 129 Inter-observer variability in gross tumour volume delineation in locally advanced non-small cell lung cancer cases: An institutional review Conference Paper
- 162 Radiation dose to the internal pudendal arteries from iodine 125 prostate brachytherapy Conference Paper
- 169 The impact of positron emission tomography (PET) in stage III non-small cell lung cancer: A prospective randomized clinical trial-improving clinical trials accrual using screening log evaluations Conference Paper
- 183 Can an In Vitro Assay Predict Radiation Sensitivity in Patients with Carcinoma of the Prostate? Conference Paper
- 226 Timing of androgen deprivation therapy after radical radiotherapy failure — A survey of Canadian practitioners Conference Paper
- 28 Supportive care service needs of newly diagnosed cancer patients: Results of a population based study Conference Paper
- 34 Phase 2 study of neoadjuvant docetaxel and androgen suppression (AS) Plus Radiation Therapy (RT) for high risk localized prostate cancer (HRLCaP) Conference Paper
- 63 Primary and adjuvant chemoradiotherapy for locally advanced pancreatic cancer: A phase I/II study with long term outcome Conference Paper
- 69 The impact of 18-fluorodeoxyglucose positron emission tomography (FDG-PET) on radiotherapy planning in carcinoma of the esophagus Conference Paper